Pharmacodynamic Modeling of Finasteride, a 5α‐Reductase Inhibitor
- 8 July 1995
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 15 (4) , 509-511
- https://doi.org/10.1002/j.1875-9114.1995.tb04389.x
Abstract
Finasteride is a 4-azasteroid inhibitor of one isoenzyme of 5 alpha-reductases that converts testosterone to dihydrotestosterone (DHT). We characterized the time course of DHT concentrations. The following model was used to assess DHT pharmacodynamics: [formula: see text] where joint fitting of three dose levels yielded kin0 = 28% change/hour, kout = 0.28 hour-1, IC50 = 0.012 ng/ml, and Emax = 0.7. The modification of a previous model with the maximum partial effect factor, Emax, may be useful in characterizing the pharmacodynamics of drugs with similar indirect mechanisms.This publication has 9 references indexed in Scilit:
- Finasteride: The First 5α‐Reductase InhibitorPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Finasteride: A slow-binding 5.alpha.-reductase inhibitorBiochemistry, 1993
- Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.Journal of Clinical Investigation, 1992
- Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide, a new type of specific competitive inhibitor of testosterone 5α-reductase, in volunteersEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*Journal of Clinical Endocrinology & Metabolism, 1990
- Androgen-Regulated Gene ExpressionAnnual Review of Physiology, 1989
- Species Differences in Prostatic Steroid 5α-Reductases of Rat, Dog, and HumanEndocrinology, 1985
- The Conversion of Testosterone to 5α-Androstan-17β-ol-3-one by Rat Prostate in Vivo and in VitroJournal of Biological Chemistry, 1968